Valley National Bancorp’s Biogen BIIB Stock Holding History

Valley National Bancorp’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$7K	Buy	+20	New	+$6.47K	0.01%	173

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Valley National Bancorp's BIIB Position: Q4 2014 in Review

Valley National Bancorp opened a new position in Biogen (BIIB) in Q4 2014: 20 shares worth $7K. The stake represents 0.01% of the portfolio and ranks #173 among its holdings.

885 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

Valley National Bancorp held 20 shares of Biogen worth $7K as of Q4 2014.
Biogen was a new Valley National Bancorp position in Q4 2014.
Biogen made up 0.01% of Valley National Bancorp's portfolio in Q4 2014, its #173 holding.
885 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Valley National Bancorp's 13F filing for Q4 2014, filed 9 Feb 2015.